INTRODUCTION
Diabetes mellitus is a common disorder associated with increased morbidity, mortality rate, and can be characterized by hyperglycemia due to defects in insulin secretion, insulin action, or both, causing metabolic and physiological changes in various organs. [1] Hyperglycemia is the important factor in the onset and progress of diabetic complications mainly by producing oxidative stress. [2] Oxidative stress may result from over production of precursors to oxygen free radicals and/or decreased effi ciency of antioxidant system. [3] Superoxide dismutase, catalase, and glutathione peroxidase (GPx) are the biological antioxidant enzymes that directly scavenge free radicals and prevent their conversion to toxic products. [4] Diabetes is associated with altered levels of these enzymes that result in increased oxidative stress, which may be caused due to several mechanisms, including glucose autoxidation and nonenzymatic glycation. [5] [6] [7] [8] The discovery of insulin was a boon for the treatment of diabetes mellitus but it fails to prevent the long-term complications. Various hypoglycemic drugs are also being used for the treatment but their use is restricted by their limited action and accompanying side effects. During the last five decades, considerable progress has been achieved regarding the biological activity and medicinal application of Azadiracta indica A Juss (Neem). Each part of Neem tree has some medicinal property and thus commercially exploitable. [9] A. indica has been commonly used to treat diabetes in Indian system of medicine from time immemorial. [10] There are several reports that suggest the hypoglycemic potential of A. indica. [11] [12] [13] The present study explores the possibility of using A. indica leaf and bark extracts, and evaluates their effect on altered level of antioxidant enzymes in different tissues of alloxan-induced diabetic rat model.
MATERIALS AND METHODS

A. indica leaf extract (aqueous)
One kilogram of freshly collected, shade dried, powdered leaves of A. indica were ground in 4 L of distilled water and allowed to soak overnight at room temperature. The suspension was then centrifuged at ×5000g for 20 min and fi ltered through Whatman No. 1 fi lter paper. The fi ltrate was lyophilized to yield 12.9 g of dry powder and stored at −20°C. A measured amount of the extract was dissolved in distilled water at a suitable concentration prior to experiment.
A. indica bark extract (aqueous)
Air dried bark from a full grown Neem tree, devoid of external hard wood was cut into small pieces and 100 g was soaked overnight in 1 L distilled water at room temperature with occasional shaking. After fi ltration, the brown red extract was lyophilized to yield 3.7 g of dry powder and stored at −20°C. A required concentration of powder was prepared in distilled water prior to experiment.
Animals treatment
Healthy female rats of Wistar strain (2-3 months old) weighing between 180 and 210 g were selected for the study. All animals were kept at 25°C-30°C and 45%-55% relative humidity, acclimatized with standard chow and water ad libitum throughout the study under 12:12 h light:dark cycle. Diabetes was induced by following the method of Sochor et al. [14] All animals were carefully monitored and experimental protocols were in accordance with the recommendations of the institutional Animal Ethical Committee. Alloxan monohydrate, insulin, and glutathione reductase (GR) were purchased from Sigma Aldrich, USA and other chemicals and reagents used were of analytical grade. The rats with fasting glucose level above 360 mg/dL were considered diabetic and randomly divided into the following groups (n=6): Group 1: Normal Control (NC) treated with vehicle alone (healthy rats with normal blood glucose level). Group 2: Diabetic Control (DC) untreated. Group 3: Insulin-treated diabetic group (D+I) (received intraperitoneal injection of 2 units of protamine-zinc insulin once daily). Group 4: A. indica Leaf Extract-treated diabetic group (D+AILE) (500 mg/kg body weight). Group 5: A. indica Bark Extract-treated diabetic group (D+AIBE) (100 mg/kg body weight).
The experimental groups received orally aqueous solution of extract by intragastric tube. For each dose, the required amount of the lyophilized powder calculated from the body weight of the animal was weighed, dissolved in distilled water at a suitable concentration so that the desired amount for each dose can be administered in 0.5 mL to each animal. To ensure the stability of the crude extracts and thus the effi cacy, the treatment was given for 21 days. Effective dosages were selected after doing pilot studies. [15] 
Estimation of enzyme activities
At the end of the experiment, rats were sacrifi ced by cervical dislocation. Liver and kidney were rapidly excised and washed with chilled normal saline. The tissues were then blotted dry and weighed. Tissue homogenates (10% w/v) were prepared in 0.25 M Sucrose, 0.02 M Triethanolamine hydrochloride buffer of pH 7.4 containing 0.12 M Dithiothreitol (DTT). Homogenates were then centrifuged at ×1000g for 10 min to remove nuclei and cell debris. The supernatant was again centrifuged at ×12,000g for 40 min to obtain cytosolic fraction. All the procedures were carried out at 4°C. The supernatants were then used for determination of enzyme activity.
The activity of superoxide dismutase (SOD) was measured by the method of Marklund and Marklund. [16] The change in absorbance was monitored at 420 nm for 3 min at 25°C against blank. One unit of enzyme activity is defi ned as the amount of enzyme that causes 50% maximal inhibition of pyrogallol autoxidation. The assay of catalase (CAT) was performed by following the method of Aebi. [17] Change in absorbance was monitored at 240 nm at 25°C. One unit of enzyme activity is defi ned as the amount of enzyme required to decompose 1 μmol of H 2 O 2 . The activity of GPx was measured using a coupled enzyme assay as described by Lawrence and Burk. [18] The decrease in absorbance was monitored at 25°C at 340 nm. One unit of enzyme activity is defi ned as 1 μmol of nicotinamide adenine dinucleotide phosphate oxidase (NADPH) oxidized/min/mg protein.
The GR activity was measured in the soluble tissue extracts by the method of Erden et al. [19] The decrease in absorbance was monitored at 25°C at 340 nm. One unit of enzyme activity is defi ned as 1 μmol of NADPH oxidized/min/mg protein. The glucose-6-phosphate dehydrogenase (G-6-PD) activity was assayed by following the method described by Cohen and Rosemeyer. [20] The change in absorbance was monitored at 340 nm for 3 min at 25°C against blank. One unit of enzyme activity is defi ned as 1 nmol NADP reduced/min/mg protein.
Lipid peroxidation
The level of lipid peroxidation was assessed by measuring the formed malondialdehyde (MDA), an end product of fatty acid peroxidation, by using thiobarbituric acid reactive substance (TBARS) method. [1] The concentration of MDA-TBA complex was determined spectrophotometrically at 532 nm against blank and results are expressed as nmol MDA formed/mg protein.
Glycemic index
Blood glucose was determined by using Glucose-kit from Span Diagnostics, India, which quantitatively estimates D-glucose, the form that is present in blood plasma. Glycosylated hemoglobin (GHbA1c) was estimated by Ion Exchange Resin method using kit purchased from Aristha Pharmaceuticals, India. Soluble protein was determined by method of Bradford using bovine serum albumin as standard. [21] 
Statistical analysis
All values were calculated as mean±SEM. The ANOVA test followed by Dunnett's multiple comparison test was employed for statistical comparison between control and various groups. Signifi cance was considered at P<0.05.
RESULTS
General parameters
All diabetic animals showed the symptoms of glycosuria, polydipsia, polyphagia, and reduced rate of growth. Physiological parameters, such as body weight, tissue weight, and tissue protein, are summarized in Table 1 . After 21 days of diabetes induction, body weight was signifi cantly reduced in the diabetic group. Both AILE and AIBE were able to restore back the body weight of the diabetic rats to control levels. Liver weight of the diabetic rats decreased when compared with that of the controls, although the same being compared on a functional basis as liver/100 g body weight did not show any signifi cant difference between the control, diabetic, and the treatment groups. There was an increase in kidney weight of diabetics as compared with the controls and the difference in the weights was even more signifi cant when expressed as per 100 g body weight.
Alloxan-induced diabetic rats showed marked hyperglycemia with almost 3-fold higher blood glucose concentration when compared with the control values [ Table 2 ]. Treatment with AILE and AIBE, however, resulted in a partial revival of euglycemia with improved body weight. As evident from Table 2 , AILE was more effective in lowering hyperglycemia in diabetic rats as compared with AIBE. Glycosylated hemoglobin, measured as % of HbA1c, was signifi cantly increased (P<0.05) in untreated diabetic animals when compared with healthy controls [ Table 2 ]. Although, the decrease of HbA1c was observed in all the diabetic-treated groups, treatment was more effective in AILE-treated group.
There was no signifi cant change in the tissue protein content of diabetic and diabetic-treated groups when compared with controls. All the enzyme activities are expressed as per milligram protein and therefore, represent true changes under these conditions.
Effect on antioxidant enzymes
As is evident from Figure 1 , SOD activity showed a significant reduction in diabetic rat liver (P<0.01), which agrees well with earlier published data. [5] Similarly, kidney showed a lower activity of SOD in the diabetic state (P<0.05). Figure 2 shows CAT activity decreasing signifi cantly in liver and kidney of diabetic rats. In diabetic state, GPx activity decreased signifi cantly in liver (P<0.05) and increased in kidney [ Figure 3 ]. GR activity decreased signifi cantly in liver and shows a small increase in the kidney of diabetic rat [ Figure 4 ]. Treatment of diabetic animals with insulin, AILE, and AIBE reversed the changes in these enzymes to control values.
In hyperglycemic rats G-6-PD activity reduced signifi cantly (P<0.01) in liver and kidney tissues [ Figure 5 ]. Treatment with insulin, AILE, and AIBE restored the altered activity close to control levels. AIBE was more effective in reversing the change in G-6-PD activity. 
Effect on lipid peroxidation
In the present study, the level of lipid peroxidation was determined in control, diabetes-induced, and diabetic rats treated with insulin and A. indica extracts, and results are summarized in Figure 6 . Lipid peroxidation was found to increase in both liver and kidney of diabetic rats as results showed signifi cant rise (P<0.05) in MDA level. Treatment with AILE and AIBE reversed the above-altered parameter to normal values. AIBE was found to be more effective in controlling diabetes induced changes in lipid peroxidation.
DISCUSSION
The present study showed that 21 days of treatment with insulin, AILE, and AIBE resulted in a marked reduction in hyperglycemia in diabetic animals and also improved the bodyweight. Therefore, after showing the improvement in glucose homeostasis in the treated animals, the metabolic consequences of this treatment in liver and kidney was further examined.
In diabetes, the persistence of hyperglycemia has been reported to cause increased production of oxygen free radicals through auto-oxidation and nonenzymatic glycation. If the diabetic state is associated with a generalized increase in tissue oxidative stress it might be refl ected in the changes in tissue antioxidant system. Therefore, the activities of some major antioxidant enzymes were measured in control and experimental rats. Diabetic rats showed altered levels of the antioxidant enzymes studied in liver and kidney, thus generating oxidative stress in these tissues. Under normal physiological condition there is a critical balance in the generation of oxygen free radicals and its antioxidant defense systems used by organism to deactivate and protect themselves against free radical toxicity. [22] Impairment in the oxidant/antioxidant equilibrium in favor of the former provokes a situation of oxidative stress, which is known to be a component of molecular and cellular tissue damage mechanisms in a wide spectrum of human diseases and contributes substantially to the pathogenesis of diabetic complications. [23] In vitro and in vivo studies have reported that in a variety of tissues, hyperglycemia and possibly elevated free fatty acid levels result in the generation of oxygen free radicals and considerably increased oxidative stress. [24] [25] [26] Various tissues are more prone to oxidative damage and could result in various complications in long-term diabetes, implying that, the restoration of antioxidant status is an important parameter to evaluate the effect of antidiabetic compound. In the present study, major antioxidant enzymes, such as SOD, CAT, GPx, and GR, are studied to evaluate the antioxidant status in liver and kidney of A. indica-treated diabetic rats. Treatment with insulin, AILE, and AIBE restored the altered levels of SOD, CAT, GPx, and GR close to their normal values in liver and kidney of diabetic rats. The effi cacy of AILE and AIBE treatment was found comparable to the insulin treatment. The mechanism responsible for the decreased activity of these enzymes in diabetic state is not fully known, it is suggested that phosphorylation and decreased expression may play a role.
NADPH is the principle intracellular reductant and the entire antioxidant system relies on an adequate supply of NADPH. G-6-PD is the principle source of NADPH, [27, 28] which is of central importance to cellular redox regulation and any changes in G-6-PD will alter NADPH levels and thus impact the entire antioxidant system and makes tissues very vulnerable to oxidative damage. [29] Also, G-6-PD is the rate limiting enzyme of pentose phosphate pathway, which helps in maintaining the normal blood glucose level. [30] Any imbalance in glucose homeostasis will result in altered activity of the enzyme. Signifi cantly, reduced activity of G-6-PD was observed in hyperglycemia-induced diabetic rats. The treatment with AILE and AIBE resulted in euglycemia and signifi cant restoration of the G-6-PD activity in liver and kidney.
Hyperglycemia has been shown to generate free radicals from auto-oxidation of glucose, formation of advanced glycated end products, and increased polyol pathway with concomitant increase in cellular lipid peroxidation and damage of cellular membranes. [31] In the present study the formation of TBARS, a product of lipid peroxidation, was signifi cantly increased in diabetic liver and kidney tissues. The results are in agreement with earlier published data of Kakkar et al., [32] and Mohamad et al. [33] This increased lipid peroxides formation during diabetes disturbs the anatomical integrity of the membrane leading to the inhibition of several membrane bound enzymes. [34] The results revealed a sharp decreased level of TBARS in diabetic rats treated with insulin, AILE and AIBE when compared to untreated diabetic rats indicating the effi cacy of treatment.
A. indica may exhibit its therapeutic effects through modulation of insulin secretion. The present study showed the hypoglycemic and antioxidant properties of A. indica. A reduction in the production of free radicals and lipid peroxides formation by restoring the antioxidant enzymes was observed in the present study, which can benefi cially prevent the diabetes-associated tissue damage. As concluded from the studied parameters, AILE and AIBE were found effective in controlling the hyperglycemia-induced oxidative stress and stabilizing the physiological parameters and antioxidant defense system. Further studies are in progress to ascertain which photochemical fraction is most effi cacious in the treatment of diabetes. 
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